Halozyme Announces FDA Approval of Bristol Myers Squibb's …
Dec 30, 2024 · Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval for Opdivo …
Halozyme Announces argenx's VYDURA with ENHANZE® was …
Dec 30, 2024 · News provided by Halozyme Therapeutics, Inc. Dec 30, 2024, 06:45 ET. Share this article. Share to X. Share this article. Share to X. SAN DIEGO, Dec ...
Halozyme reports FDA approval for Opdivo co-formulated with
Dec 30, 2024 · Halozyme (HALO) announced that Bristol Myers Squibb (BMY) received FDA approval for Opdivo Qvantig co-formulated with Halozyme’s Enhanze drug delivery technology …
News | Halozyme
Halozyme provides disruptive drug delivery solutions with the goal of improving patient experiences and outcomes that can enhance the competitiveness of emerging and established …
Halozyme Therapeutics, Inc. (HALO) Latest Stock News
Get the latest Halozyme Therapeutics, Inc. (HALO) stock news and headlines to help you in your trading and investing decisions.
Halozyme Therapeutics Inc. - MarketWatch
Dec 30, 2024 · HALO | Complete Halozyme Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial
Nov 22, 2024 · Halozyme Therapeutics on Friday said it withdrew an offer to buy Evotec after the German drug discovery and contracting company refused to engage in acquisition talks.
Halozyme maintains 2024 revenue forecast despite patent …
Oct 24, 2024 · SAN DIEGO - Halozyme (NASDAQ: HALO) Therapeutics, Inc. (NASDAQ: HALO) announced today that the revocation of a co-formulation patent by the European Patent Office …
Halozyme’s Patent Challenges and New Licensing Platform Lead …
Oct 25, 2024 · In addition to the patent issues, Halozyme introduced a new licensing platform, MDASE, which could potentially attract companies looking to mitigate litigation risks.
Halozyme: Recent Approvals Alter My Appetite - Seeking Alpha
Dec 31, 2024 · Halozyme's attempt to acquire Evotec was a bold move to diversify revenue, but was ultimately unsuccessful, impacting HALO's stock price. Read more here. ... and …
- Some results have been removed